Cellectis Combined General Shareholders’ Meeting of June 14, 2013
6/18/2013 12:20:27 PM
More...
|
TAL-Effector Nuclease: The USPTO Issues a Third Patent Licensed to Cellectis
5/28/2013 11:11:46 AM
More...
|
Cellectis: TAL-effector Nuclease: Issuance by the USPTO of Two New Patents
5/16/2013 10:54:25 AM
More...
|
Precision BioSciences Wins Patent Infringement Lawsuit Against Cellectis
5/6/2013 10:17:37 AM
More...
|
David Sourdive, Vice President of Corporate Development at Cellectis, Has Been Appointed by French Foreign Trade Minister Nicole Bricq to Boost France's Export Performance in the Health Sector
5/2/2013 12:13:51 PM
More...
|
Cellectis: 2012 Financial Results
4/30/2013 6:40:06 AM
More...
|
Cellectis: An Innovative Anti-cancer Approach
12/18/2012 9:24:11 AM
More...
|
Cellectis Presents Breakthrough in Fight Against Cancer at ESGCT Congress
10/29/2012 6:41:43 AM
More...
|
CELLECTIS SA Extends Its TAL Technology Intellectual Property Portfolio Through the Acquisition of Two Exclusive Licenses From Iowa State University
10/25/2012 10:07:40 AM
More...
|
Medicago, Inc. and CELLECTIS SA Successfully Achieve First Step in Research Collaboration
10/4/2012 10:33:50 AM
More...
|
|